Neonatal intensive care unit (NICU) providers are continually challenged by the task of providing skin care to the very low birth weight (VLBW) infant. Intact skin is the premature infant's principal barrier to infection, absorption of chemicals, and fluid loss. 1 Skin permeability is inversely proportional to the degree of prematurity. 1 Increased skin permeability predisposes the VLBW infant to increased transepidermal water loss (TEWL), to absorption of commonly used topical agents such as povidone-iodine and alcohol, and to mechanical and thermal injury and infection. 2 The large ratio of surface area to body weight, in conjunction with an immature stratum corneum, compounds TEWL. 3 Increased TEWL can, in turn, result in clinically significant fluid and electrolyte imbalances in the first postnatal days.
VLBW infants are prone to skin breakdown as a result of accidental epidermal stripping. Skin breakdown can augment the rate of TEWL, while providing a portal of entry for microorganisms that can lead to bacteremia. Infants born at Ͻ28 weeks' gestation, or with birth weight of Ͻ1000 gm, and aged Ͻ2 postnatal weeks old are at greatest risk for iatrogenic complications related to the integrity of their skin.
Most NICU guidelines for the care of the skin of the VLBW infant are based on empirical or anecdotal data. There are several studies that measure efforts to decrease TEWL. These studies include the use of paraffin wax wraps, 3, 4 plastic blankets, 3, 5 humidity, 6 and artificial skin barriers. [7] [8] [9] All these methods have been shown to reduce TEWL. There have been few studies regarding the safe use of emollient therapy for this at-risk population, and most of the infants studied have been of Ͼ30 weeks' gestation.
10,11 Accordingly, we undertook to study the effect of repeated application of an occlusive ointment (Aquaphor; Beiersdorf Inc., Norwalk, CT) on the skin condition and skin bacterial flora of a cohort of infants Յ30 weeks' gestation.
METHODS

Design
Nineteen infants 26 to 30 weeks' gestational age and Ͻ24 hours old were enrolled and randomly assigned to control or treatment groups. Gestational age was assessed using the modified Ballard scoring system. 12 Before enrollment and after the nature of the experimental procedure had been fully explained, written informed consent was obtained from the parents. This protocol was approved by the Institutional Review Board of the University of Maryland at Baltimore.
The control groups received routine skin care, which included an initial soap and water bath plus plain sterile water baths, as determined by the NICU nursing staff, for the next 2 weeks. The use of lotions and creams was avoided. Adhesives were used sparingly, and povidone-iodine preparations used for intravenous line insertions and for sepsis work-ups were removed with sterile water after the procedure was completed. In addition to this routine skin care, the treatment groups received 1.5 ml of Aquaphor applied to the entire body except the face and scalp. Treatment began within the first 24 hours of life; thereafter, ointment was applied twice daily (at 8:00 AM and 8:00 PM) for 14 days. All but two infants were placed in double-walled incubators by the fourth day of life.
Skin Condition
Skin condition was measured using the numeric scoring system of Lane and Drost, 10 which focuses on skin dryness, scaling, erythema, and fissuring. Before initiation of therapy, the skin was assessed with emphasis on the condition of the abdominal area and the dorsum of the hands and feet. Scores (0 to 9) were given for the emphasis areas and were then averaged for a total score (0 to 9). Two investigators (RCP and KPS), blinded to group assignment, evaluated the same areas of the skin of each neonate at enrollment and then twice a week, for 2 weeks, for a total of five skin assessments. Assessments were performed 8 to 10 hours after application of the ointment to decrease the greasy appearance of the skin and to ensure that the scorers remained blinded. The skin was viewed, not touched, by the investigator so that the texture of the skin did not influence scoring. If adhesive (or other) trauma was present on an emphasis area, no score was given for that area and the final score was the average of the remaining areas. Inter-rater reliability was established by double rating a random sample of subjects on a weekly basis; there was 95% agreement on scores between the two evaluators.
Fluid Requirements
Total fluid input (ml/kg per day) and urine output (ml/kg per day) were assessed daily, and maximum serum sodium concentrations were tabulated. The percentage weight loss from birth weight at the end of the 2-week study period and the maximum percentage weight loss from birth weight were also calculated.
Bacterial Sampling and Identification
Sterile cotton swabs (Culturette; Becton Dickinson, Sparks, MD) were gently rubbed over a 1-cm 2 area on the axilla or abdomen. They were then placed in transport tubes and immediately delivered to the microbiology laboratory. Swabs were placed in 1 ml of sterile normal saline and vigorously vortexed to ensure that adherent microorganisms were removed. Serial 100-fold dilutions (10 Ϫ2 to 10 Ϫ4 ) were performed using sterile normal saline. 100 l from each sample (including the original undiluted specimen) was plated on tryptic soy agar containing 5% defibrinated sheep blood for recovery of aerobic bacteria, Sabouraud's dextrose agar for recovery of yeast, and Sabouraud's dextrose agar containing a sterile olive oil overlay for recovery of Malassezia furfur. 13 Agar plates were incubated at 35°C for bacteria and 30°C for yeast and examined and enumerated at 24, 48, and 72 hours. API STAPH, API 20S, and API 20C (bioMerieux, Inc., St. Louis, MO) were used to speciate coagulase-negative staphylococci, enterococci, and yeast, respectively. Corynebacterium spp. and Micrococcus spp. were identified by characteristic Gram stain morphology and absence or presence of catalase activity.
14 M. furfur was identified by Gram stain morphology and nutritional requirements. 13 All infants received ampicillin and gentamicin for at least the first 3 days of life.
Statistics
Two-way, repeated-measures analysis of variance (ANOVA) was used to measure the interaction between treatment and time on skin condition, fluid balance (total fluid intake, urine output, and intake minus urine output), and maximum serum sodium concentration. Dunnett's post-hoc test was used to compare different times to baseline. Treated and untreated infants were compared at different time points using unpaired two-tailed Student's t-tests. Repeated-measures ANOVA was also used to assess quantitative changes in bacterial flora over time. Maximum percentage weight loss and percentage change from birth weight at the end of 2 weeks were compared using unpaired two-tailed Student's t-tests.
RESULTS
There were no significant differences in gestational age, birth weight, Apgar scores, incidence of patent ductus arteriosus, or time on phototherapy or on ventilators between treatment and control groups (Table 1). Five infants developed nosocomial infections. Two infants in the treated group developed coagulase-negative bacteremia on days 11 and 26, respectively, and one infant in this group developed (culture-negative) necrotizing enterocolitis. Two control infants developed culture-proven bloodstream infection: one infant developed an Enterobacter bacteremia on day 23, followed by candidemia on day 53, and a second infant developed late-onset group B streptococcal bacteremia. Skin condition scores in treatment and control groups did not differ at the time of study entry (0.49 Ϯ 0.72 SD for the treated group; 0.46 Ϯ 0.71 SD for the controls). Skin condition was significantly better in the Aquaphor-treated group ( p Ͻ 0.002; 2-way, repeatedmeasures ANOVA). The group that did not receive Aquaphor ointment had significant worsening of skin condition scores over time ( p Ͻ 0.012) and differed significantly from the treated group at each time point; the scores in the treated group did not change over the 2-week study period (Figure 1 ).
There were no significant differences between the treatment and control groups with respect to total fluid receipt over the 2-week study period (Figure 2, A) . Although the control group received slightly more fluid on most study days, taken individually, the differences were not found to reach statistical significance. Urine output was slightly lower in the control group, although the differences were not significant (data not shown). The daily difference between total fluid intake and urine output was slightly higher in the control group ( p ϭ 0.08; 2-way, repeated-measures ANOVA [ Figure 2, B] ). There were no differences in serum sodium concentrations between the two groups over the 2-week study period (data not shown).
There were no significant differences in weight at the end of the 2-week study period (98.5 Ϯ 6.2% [SD] of birth weight in the treated infants versus 96.1 Ϯ 4.0% in the control infants) or in maximal percentage weight loss from birth weight (14.9 Ϯ 3.8% [SD] in treated babies versus 14.7 Ϯ 3.2% in controls).
Abdominal and axillary skin cultures were sterile at baseline in the majority of infants. The predominant skin flora for both cohorts consisted of various coagulase-negative staphylococci, with Staphylococcus epidermidis being by far the most common. Other bacterial species, if and when present, were represented by quantitatively few CFU/ml. By the second week of life, M. furfur had emerged as the second most common skin floral species, with 5 of 11 treated infants There were no significant differences between control and treated groups. B, Daily fluid intake minus urine output (ϮSEM) over the first 2 weeks of life; p ϭ 0.08; 2-way, repeated-measures ANOVA. and 3 of 8 controls having Malassezia cultured at least once. There were no discernible differences in skin microfloral patterns between treated and untreated infants ( Table 2) .
Quantitative bacterial counts are given in Table 3 . For the entire population, quantitative bacterial counts increased over time at both the axillary ( p ϭ 0.006; repeated-measures ANOVA) and abdominal sampling sites ( p Ͻ 0.001). There were no significant differences between the control and treated groups in quantitative bacterial counts.
DISCUSSION
The skin is the largest organ of the premature infant's body, making up 13% of total body weight, versus 3% in the adult. 1, 15 Stratum corneum integrity in skin provides first-line barrier properties. At 24 weeks' gestation the stratum corneum is two to three cells thick. By 34 weeks' gestation, increased thickness of the epidermis and further maturation of the stratum corneum generally provide a sufficient barrier that protects against skin breakdown, TEWL, and absorption of chemicals. 1, 15 Extrauterine life accelerates maturation of the skin, so that by 2 to 3 weeks of postnatal life, the skin is functionally mature regardless of the initial degree of prematurity, presumably secondary to the change from a fluid to a gaseous environment.
1 Maternal steroid administration has also been shown to accelerate skin maturation in rats. 16, 17 The skin of all newborns is sterile at birth, 1 with colonization beginning directly after birth. Colonization counts rise rapidly during the first 7 days of life and are unrelated to skin maturity. 18 Neither a premature infant's immune response nor its anatomic barrier may be adequate to localize and protect a VLBW infant from invasion by foreign pathogens. 19 Keyworth et al. 18 found that the skin of premature infants had a higher colonization rate with coagulase-negative staphylococci than with full-term infants, presumably secondary to contamination and repeated inoculation during handling by caregivers, thus placing the premature infant at greater risk for bacteremia caused by coagulase-negative staphylococci. The same is true regarding colonization of premature infant skin with M. furfur, a highly lipophilic fungus, which has been implicated in sepsis in VLBW infants. 20 Poor skin integrity may be a more frequent mode of microorganism entry than invasive procedures.
Previously studied methods of controlling TEWL may place infants at risk for temperature instability, infection, or accidental epidermal stripping. Although humidity is effective in controlling TEWL, 6 safe temperatures and percentages for use are not well documented. Condensation may increase the frequency of cold stress experienced when isolettes are opened or plastic tents are removed when these premature infants are handled by caregivers. The temptation to remove occlusive dressings early may result in denuded preterm skin. Plastic or paraffin wraps were found to be effective in preventing TEWL, 3, 4 but these studies did not directly comment on skin condition. Occasionally, infants treated with paraffin wraps experienced skin rashes, described as "blotchy, erythematous, and of the heat rashes type." 3 Over-the-counter topical skin agents are often used to promote cleanliness, retain moisture, and provide protection from the environment. 21 Given the extreme permeability of VLBW skin to a variety of toxic substances, including povidone-iodine 22, 23 and isopropyl alcohol, 24 it is necessary to examine any preparation to be used on infants for potential toxicity, including irritation, allergic sensitization, or percutaneous toxicity. Phototherapy burns do not occur more frequently with topical emollients.
Aquaphor ointment was chosen as the topical agent in this study because it has no preservatives and is easy to spread. It has been found safe for use under phototherapy. 11 It is unlikely to be absorbed by preterm skin due to the large molecular size of its main ingredient, petrolatum. 4 Water-soluble agents are more easily miscible in Aqua- phor than in plain petrolatum. There is a theoretical disadvantage of sensitization to the wool wax alcohols in Aquaphor. Aquaphor ointment is the derivative for the base of Eucerin cream (Beiersdorf Inc.), which was previously studied by Lane and Drost 10 and found to be effective in preventing cracks and fissures in infants Ͻ 34 weeks' gestational age without changing the skin microbial flora.
Recently, Nopper et al. 11 tested Aquaphor ointment on the skin of infants Ͻ 33 weeks' gestational age. Findings included improved skin condition by day 7 of the study, decreased TEWL on day 14, and decreased axillary bacterial colonization counts on days 2 through 4 and 14. Infants in the treatment group had fewer culture-documented cases of sepsis. They reported no adverse reactions, even with concomitant use of phototherapy. Our results are generally in accord with these data and extend them to a somewhat smaller and less mature population. As in their study, we found significant differences in skin condition between treatment and control groups and no significant differences in qualitative skin flora. Minor changes in fluid balance were noted. The greater differences in fluid input minus urine output in the control group, taken in context with the lack of differences in percentage weight gain or loss over the study period would be consistent with greater losses through the skin. However, this remains speculative without direct measurements of TEWL. We were able to document improvement in skin condition as early as day 4 of life. However, we found no quantitative difference in skin bacterial counts in either abdominal or axillary cultures. There are a number of minor variations between our study and that of Nopper et al. 11 They enrolled infants up to 4 days of age, so that time 0 and subsequent study days differed in each infant; unfortunately time of enrollment is not reported for the two groups. In addition, they did not stratify their population, which included 20 infants of Ͻ1000 gm (out of 60 enrollees) and some infants of 24 and 25 weeks' gestation. This may be of importance, because we have found skin scores, in a pilot study of seven infants of 23 to 25 weeks' gestation, to be dramatically higher in both treated and untreated infants (unpublished observations). Therefore, it is possible that results of treatment with Aquaphor ointment will be more impressive in this highest risk group of infants; however, safety, in terms of skin colonization, predisposition to sepsis, and skin irritation, will have to be determined specifically in this group before Aquaphor treatment can be advocated for infants of gestational age Ͻ 26 weeks. In addition, Nopper et al. 11 reported that 6 hours after the application of Aquaphor ointment, the improvement in TEWL was greatly reduced, suggesting that, at least with respect to TEWL, more frequent applications are needed. Thus, our results indicating only minor changes in fluid balance may reflect the 12-hour interval between applications in our protocol design. Nevertheless, the 12-hour interval appears sufficient to maintain the differences in skin scores. Overall, the data suggest that 6-to 8-hour applications of Aquaphor would be appropriate in the NICU setting.
In summary, repeated applications of Aquaphor ointment beginning on the first day of life and continuing for 2 weeks appear to offer protection against epidermal breakdown in preterm infants of gestational age as low as 26 weeks, without changing cutaneous bacteria and yeast. These studies should be extended to infants Ͻ 26 weeks' gestation, because it is this group that is at highest risk for complications related to skin immaturity.
